1
NBME 31
NBME 31 TEST 2 (2025/2026 UPDATE)
QUESTIONS & ANSWERS |GRADE A|100%
CORRECT (VERIFIED SOLUTION)
1. ________________ is used in the symptomatic management
of heart failure because of its cardiotonic properties, which arise
from inhibiting the transmembrane enzyme Na+-K+ ATPase. This
leads to an increased intracellular calcium concentration, with
increased force of contraction, relieving symptoms of heart
failure.: Digoxin
2. Digoxin is used in the ___________________ management of
heart failure because of its cardiotonic properties, which arise
from inhibiting the transmembrane enzyme Na+-K+ ATPase. This
leads to an increased intracellular calcium concentration, with
increased force of contraction, relieving symptoms of heart
failure.: symptomatic; heart failure
NBME 31
,3. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
_________________ the transmembrane enzyme
__________________________. This leads to an increased
intracellular calcium concentration, with increased force of
contraction, relieving symptoms of heart failure.: inhibiting; Na+-K+
ATPase
4. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
inhibiting the _______________________ Na+-K+ ATPase. This
leads to an increased intracellular calcium concentration, with
increased force of contraction, relieving symptoms of heart
failure.: transmembrane enzyme
5. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
inhibiting the transmembrane enzyme Na+-K+ ATPase. This leads
to an __________________________ concentration, with
, increased force of contraction, relieving symptoms of heart
failure.: increased intracellular calcium
6. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
inhibiting the transmembrane enzyme Na+-K+ ATPase. This leads
to an increased intracellular calcium concentration, with
__________________________, relieving symptoms of heart
failure.: increased force of contraction
7. A 57-year-old woman with hypertension and hyperlipidemia
comes to the physician for a follow-up examination. She has
smoked 1 pack of cigarettes daily for the past 40 years. When the
physician asks the patient if she is interested in quitting smoking,
she replies that she might like to quit sometime in the next 6
months, but she feels ambivalent about giving up her "crutch."
This patient is most likely at which of the following stages of
change?: contemplation
NBME 31
NBME 31 TEST 2 (2025/2026 UPDATE)
QUESTIONS & ANSWERS |GRADE A|100%
CORRECT (VERIFIED SOLUTION)
1. ________________ is used in the symptomatic management
of heart failure because of its cardiotonic properties, which arise
from inhibiting the transmembrane enzyme Na+-K+ ATPase. This
leads to an increased intracellular calcium concentration, with
increased force of contraction, relieving symptoms of heart
failure.: Digoxin
2. Digoxin is used in the ___________________ management of
heart failure because of its cardiotonic properties, which arise
from inhibiting the transmembrane enzyme Na+-K+ ATPase. This
leads to an increased intracellular calcium concentration, with
increased force of contraction, relieving symptoms of heart
failure.: symptomatic; heart failure
NBME 31
,3. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
_________________ the transmembrane enzyme
__________________________. This leads to an increased
intracellular calcium concentration, with increased force of
contraction, relieving symptoms of heart failure.: inhibiting; Na+-K+
ATPase
4. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
inhibiting the _______________________ Na+-K+ ATPase. This
leads to an increased intracellular calcium concentration, with
increased force of contraction, relieving symptoms of heart
failure.: transmembrane enzyme
5. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
inhibiting the transmembrane enzyme Na+-K+ ATPase. This leads
to an __________________________ concentration, with
, increased force of contraction, relieving symptoms of heart
failure.: increased intracellular calcium
6. Digoxin is used in the symptomatic management of heart
failure because of its cardiotonic properties, which arise from
inhibiting the transmembrane enzyme Na+-K+ ATPase. This leads
to an increased intracellular calcium concentration, with
__________________________, relieving symptoms of heart
failure.: increased force of contraction
7. A 57-year-old woman with hypertension and hyperlipidemia
comes to the physician for a follow-up examination. She has
smoked 1 pack of cigarettes daily for the past 40 years. When the
physician asks the patient if she is interested in quitting smoking,
she replies that she might like to quit sometime in the next 6
months, but she feels ambivalent about giving up her "crutch."
This patient is most likely at which of the following stages of
change?: contemplation
